The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Organosilicon Molecules with Medicinal Applications
Open accessAbstract
The incorporation of silicon and synthesis of organosilicon small molecules provide unique opportunities for medicinal applications. The biological investigation of organosilicon small molecules is particularly interesting because of differences in their chemical properties that can contribute to enhanced potency and improved pharmacological attributes. Applications such as inhibitor design, imaging, drug release technology, and mapping inhibitor binding are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Silicon in organic, organometallic, and polymer chemistry
(2001) · Choice Reviews Online · doi:10.5860/choice.38-4470 · Cited by 1,546
Cancer Therapies Utilizing the Camptothecins: A Review of the in Vivo Literature
Venditto, V. J., & Simanek, E. E. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900243b · Cited by 452
Chemistry challenges in lead optimization: silicon isosteres in drug discovery
Showell, G. A., & Mills, J. S. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02726-0 · Cited by 427
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate
Regan, J., Breitfelder, S., Cirillo, P., Gilmore, T., Graham, A. G., Hickey, E., Klaus, B., Madwed, J., Moriak, M., Moss, N., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020057r · Cited by 348
Richardson, P. G., Hideshima, T., & Anderson, K. C. (2003) · Cancer Control · doi:10.1177/107327480301000502 · Cited by 292
Dufaud, V., & Basset, J. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19980403)37:6<812::aid-anie812>3.0.co;2-i · Cited by 282
18F‐Labeling of Peptides by means of an Organosilicon‐Based Fluoride Acceptor
Schirrmacher, R., Bradtmöller, G., Schirrmacher, E., Thews, O., Tillmanns, J., Siessmeier, T., Buchholz, H. G., Bartenstein, P., Wängler, B., Niemeyer, C. M., et al. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600795 · Cited by 234
A Review of the Fate and Effects of Silicones in the Environment
Graiver, D., Farminer, K. W., & Narayan, R. (2003) · Journal of Polymers and the Environment · doi:10.1023/a:1026056129717 · Cited by 216
Synthesis and Cellular Profiling of Diverse Organosilicon Small Molecules
Franz, A. K., Dreyfuss, P. D., & Schreiber, S. L. (2007) · Journal of the American Chemical Society · doi:10.1021/ja067552n · Cited by 196
Self-citationGately, S., & West, R. (2007) · Drug Development Research · doi:10.1002/ddr.20177 · Cited by 178
Exploitation of silicon medicinal chemistry in drug discovery
MILLS, J. S., & Showell, G. A. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.9.1149 · Cited by 157
Silanediol Protease Inhibitors: From Conception to Validation
Sieburth, S. M., & Chen, C. (2005) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200500508 · Cited by 150
Incorporation and Controlled Release of Silyl Ether Prodrugs from PRINT Nanoparticles
Parrott, M. C., Finniss, M. C., Luft, J. C., Pandya, A., Gullapalli, A., Napier, M. E., & DeSimone, J. M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301710z · Cited by 133
Tacke, R., Popp, F., Müller, B., Theis, B., Burschka, C., Hamacher, A., Kassack, M. U., Schepmann, D., Wünsch, B., Jurva, U., et al. (2007) · ChemMedChem · doi:10.1002/cmdc.200700205 · Cited by 104
Kim, Y.-M., Farrah, S. R., & Baney, R. H. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.036 · Cited by 97
Gabizon, A., Tzemach, D., Horowitz, A. T., Shmeeda, H., Yeh, J., & Zalipsky, S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1547 · Cited by 97
Silanediol Hydrogen Bonding Activation of Carbonyl Compounds
Tran, N. T., Min, T., & Franz, A. K. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201101492 · Cited by 93
Self-citationPujals, S., Fernández‐Carneado, J., Kogan, M. J., Martínez, J., Cavelier, F., & Giralt, E. (2006) · Journal of the American Chemical Society · doi:10.1021/ja060036c · Cited by 91
Wängler, C., Waser, B., Alke, A., Iovkova, L., Buchholz, H., Niedermoser, S., Jurkschat, K., Fottner, C., Bartenstein, P., Schirrmacher, R., et al. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100316c · Cited by 91
Johansson, T., Weidolf, L. O. G., Popp, F., Tacke, R., & Jurva, U. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028449 · Cited by 75
Prins‐Type Synthesis and SAR Study of Cytotoxic Alkyl Chloro Dihydropyrans
Miranda, P. O., Padrón, J. M., Padrón, J. M., Padrón, J. I., Padrón, J. I., Villar, J. M., & Martı́n, V. S. (2006) · ChemMedChem · doi:10.1002/cmdc.200500057 · Cited by 73
Daiss, J. O., Burschka, C., MILLS, J. S., Montana, J. G., Showell, G. A., Fleming, I., Gaudon, C., Ivanova, D. I., Gronemeyer, H., & Tacke, R. (2005) · Organometallics · doi:10.1021/om040143k · Cited by 62
Serine Protease Inhibition by a Silanediol Peptidomimetic
Singh, S., & Sieburth, S. M. (2012) · Organic Letters · doi:10.1021/ol301933n · Cited by 57
(R)-Sila-venlafaxine: A selective noradrenaline reuptake inhibitor for the treatment of emesis
Showell, G. A., Barnes, M. J., Daiss, J. O., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.12.062 · Cited by 57
Efficient, Enantioselective Assembly of Silanediol Protease Inhibitors
Bo, Y., Singh, S., Hoàn, D. Q., Cao, C., & Sieburth, S. M. (2011) · Organic Letters · doi:10.1021/ol2002978 · Cited by 53
Juers, D. H., Kim, J. C., Matthews, B. W., & Sieburth, S. M. (2005) · Biochemistry · doi:10.1021/bi051346v · Cited by 52
Gas-Phase Acidity Studies of Dual Hydrogen-Bonding Organic Silanols and Organocatalysts
Liu, M., Tran, N. T., Franz, A. K., & Lee, J. K. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo201214x · Cited by 48
Self-citationNovel fluorinated polysilsesquioxane hollow spheres: synthesis and application in drug release
Dong, F., Guo, W., Chu, S.-W., & Ha, C. (2010) · Chemical Communications · doi:10.1039/c0cc01658f · Cited by 45
Madsen, J. L. H., Andersen, T. L., Santamaria, S., Nagase, H., Enghild, J. J., & Skrydstrup, T. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301000k · Cited by 32
Rew, Y., McMinn, D. L., Wang, Z., He, X., Hungate, R. W., Jaén, J. C., Sudom, A. M., Sun, D., Tu, H., Ursu, S., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.058 · Cited by 30
Tacke, R., Müller, V., Büttner, M. W., Lippert, W. P., Bertermann, R., Daiss, J. O., Khanwalkar, H., Furst, A., Gaudon, C., & Gronemeyer, H. (2009) · ChemMedChem · doi:10.1002/cmdc.200900257 · Cited by 29
Design of silicon-based misonidazole analogues and 18F-radiolabelling
Bohn, P., Deyine, A., Azzouz, R., Bailly, L., Fiol‐Petit, C., Bischoff, L., Fruit, C., Marsais, F., & Véra, P. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.06.004 · Cited by 27
SiFA‐Modified Phenylalanine: A Key Compound for the Efficient Synthesis of 18F‐Labelled Peptides
Iovkova, L., Könning, D., Wängler, B., Schirrmacher, R., Schoof, S., Arndt, H., & Jurkschat, K. (2011) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201100142 · Cited by 24
Chiu, F.-T., Chang, Y. H., Ӧzkan, G., Zon, G., Fichter, K. C., & Phillips, L. R. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710517 · Cited by 14
Synthesis of lipophilic sila derivatives of N‐acetylcysteineamide, a cell permeating thiol
Zakai, U. I., Bikzhanova, G. A., Staveness, D., Gately, S. T., & West, R. (2009) · Applied Organometallic Chemistry · doi:10.1002/aoc.1572 · Cited by 9
Cited by
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds
Ramesh, R., & Reddy, D. S. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00718 · Cited by 624
Directed evolution of cytochrome c for carbon–silicon bond formation: Bringing silicon to life
Kan, S. B. J., Lewis, R. D., Chen, K., & Arnold, F. H. (2016) · Science · doi:10.1126/science.aah6219 · Cited by 579
Estrogen receptor ligands: a review (2013-2015)
Farzaneh, S., & Zarghi, A. (2016) · Scientia Pharmaceutica · doi:10.3390/scipharm84030409 · Cited by 71
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation
Jachak, G. R., Ramesh, R., Sant, D. G., Jorwekar, S. U., Jadhav, M. R., Tupe, S. G., Deshpande, M. V., & Reddy, D. S. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00245 · Cited by 52
Metadata
- Authors
- Franz, A. K., & Wilson, S. O.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-11-06
- Volume
- 56
- Issue
- 2
- Pages
- 388-405
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2327593192
- Cited by
- 1,151
- References
- 36
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.